Skip to main content

Molecular Medical Imaging

The Molecular Medical Imaging research group focuses its activity on deepening the molecular bases and developing new areas of research in molecular signaling pathways and the identification of new theranostic targets.

We promote the confluence of basic and clinical researchers, experts in imaging and molecular biology to provide:

  • Access to knowledge of the biokinetics and biodistribution of the molecules under study
  • The proofs of concept necessary in the research processes
  • The identification and quantification of the targets defined by the research groups of our center

In this context, the creation of a translational imaging unit constitutes a basic objective for the development of research aimed at the personalized treatment of patients.

The group is made up of medical specialists in molecular imaging, chemists and pharmacists specializing in tracer synthesis, and biomedical engineers and physicists specializing in image processing and tomography equipment. These are affiliated with different institutions, such as the Vall d'Hebron Research Institute (VHIR), the Vall d'Hebron University Hospital (HUVH) and the Institute of Diagnostic Imaging (IDI).

Team

Fiorella Dellepiane Clarke

Fiorella Dellepiane Clarke

Postdoctoral researcher
Molecular Medical Imaging
Read more
Gemma Cuberas Borros

Gemma Cuberas Borros

Research technician
Molecular Medical Imaging
Read more
Hector García  Fernandez

Hector García Fernandez

Research technician
Molecular Medical Imaging
Read more
Hug Cuellar Calabria

Hug Cuellar Calabria

Senior researcher
Molecular Medical Imaging
Read more
Ignacio Navales  Mateu

Ignacio Navales Mateu

Molecular Medical Imaging
Read more
Inés Carolina Balón  Llerena

Inés Carolina Balón Llerena

Administration and Management
Molecular Medical Imaging
Read more
Fiorella Dellepiane Clarke

Fiorella Dellepiane Clarke

Postdoctoral researcher
Molecular Medical Imaging
Read more
Gemma Cuberas Borros

Gemma Cuberas Borros

Research technician
Molecular Medical Imaging
Read more
Hector García  Fernandez

Hector García Fernandez

Research technician
Molecular Medical Imaging
Read more
Hug Cuellar Calabria

Hug Cuellar Calabria

Senior researcher
Molecular Medical Imaging
Read more
Ignacio Navales  Mateu

Ignacio Navales Mateu

Molecular Medical Imaging
Read more
Inés Carolina Balón  Llerena

Inés Carolina Balón Llerena

Administration and Management
Molecular Medical Imaging
Read more

Projects

The Vall d’Hebron Iniciative for Parkinson associated to GBA (VHIP-GBA): from biospecimen collection to translational studies and therapies.

IP: Marta Martínez Vicente
Collaborators: José Antonio Arranz Amo, Jorge Hernández Vara, Eddie Pradas Gracia, Guillem Pintos Morell, Clara Carnicer Cáceres, Carles Lorenzo Bosquet, David Moreno Martinez, Jordi Riera Heredia, Marta Montpeyó Garcia-Moreno, Daniela Samaniego Toro, Laura Castillo Ribelles, Daniela Samaniego Toro
Funding agency: Instituto de Salud Carlos III
Funding: 245932.5
Reference: PI20/00728
Duration: 01/01/2021 - 30/06/2025

Role of sarcopenia in the evolution of morbidly obese patients who undergo bariatric surgery. Study of cohorts and mechanisms involved.

IP: Andreea Ciudin Mihai
Collaborators: Oscar González López, Fiorella Ximena Palmas Candia, Marina Giralt Arnaiz, Marta Comas Martínez, Rosa Burgos Peláez, Irene Hernández Hernández, Enzamaría Fidilio Meli, Efráin Santiago Cordero Vázquez, Cristina Gamez Cenzano
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI20/01086
Duration: 01/01/2021 - 31/12/2024

Characterization of the CD8 T cell response in Parkinson’s disease for the development of preventive and therapeutic strategies that halt the progression of the disease: SARS-Cov-2-induced long term-hyposmia as a possible prodromal stage

IP: Jordi Bove Badell
Collaborators: Miquel Vila Bover, Alejandro Ferré Masó, Oriol de Fabregues-Boixar Nebot, Carles Lorenzo Bosquet, Thais Cuadros Arasa, Antonio Palasi Franco, David Ramos Vicente
Funding agency: Instituto de Salud Carlos III
Funding: 165770
Reference: PI21/01358
Duration: 01/01/2022 - 30/06/2026

A phase I trial of ABTL0812 in paediatric patients with advanced cancer including neuroblastoma

IP: Lucas Moreno Martín-Retortillo
Collaborators: Cristina Gamez Cenzano, Aroa Soriano Fernández, Luis Riera Soler, Miguel Segura Ginard, Carlota Aguilera Ordoñez, Sergio Manresa Vera
Funding agency: Instituto de Salud Carlos III
Funding: 826760.77
Reference: ICI21/00076
Duration: 01/01/2022 - 31/12/2025

Publications

Follicular Thyroid Carcinoma Metastases on Round Ligament of Liver.

PMID: 33512955
Journal: CLINICAL NUCLEAR MEDICINE
Year: 2021
Reference: Clin Nucl Med. 2021 Apr 1;46(4):326-328. doi: 10.1097/RLU.0000000000003526.
Impact factor: 7.794
Publication type: Letter or abstract
Authors: Monturiol-Duran, Jaime Alejando, Iglesias-Felip, Carmela, Villasboas-Rosciolesi, Diego, Castell-Conesa, Joan, Garcia-Burillo, Amparo et al.
DOI: 10.1097/RLU.0000000000003526

Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI).

PMID: 33495853
Journal: BASIC RESEARCH IN CARDIOLOGY
Year: 2021
Reference: Basic Res Cardiol. 2021 Jan 25;116(1):4. doi: 10.1007/s00395-021-00842-2.
Impact factor: 17.165
Publication type: Paper in international publication
Authors: Garcia Del Blanco, Bruno, Otaegui, Imanol, Rodriguez-Palomares, Jose F, Bayes-Genis, Antoni, Sambola, Antonia, Lidon, Rosa M, Baneras, Jordi, Elizaga, Jaime, Padilla, Ferran, Barrabes, Jose A et al.
DOI: 10.1007/s00395-021-00842-2

A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.

PMID: 33497314
Journal: RADIOLOGY
Year: 2021
Reference: Radiology. 2021 Apr;299(1):109-119. doi: 10.1148/radiol.2021200928. Epub 2021 Jan 26.
Impact factor: 11.105
Publication type: Paper in international publication
Authors: Felip, Enriqueta, Villacampa, Guillermo, Raciti, Maria V, Landa, Jaid, Matos, Ignacio, Martin-Liberal, Juan, Ochoa-de-Olza, Maria, Hierro, Cinta, Mateo, Joaquin, Gonzalez, Macarena et al.
DOI: 10.1148/radiol.2021200928

The (18)F phantom clinical trials qualification for (18)F-FDG-PET scanning adopted by GELTAMO (Grupo Espanol de Linfomas/Trasplante Autologo de Medula Osea).

PMID: 33485832
Journal: Revista Espanola de Medicina Nuclear e Imagen Molecular
Year: 2021
Reference: Rev Esp Med Nucl Imagen Mol. 2021 May-Jun;40(3):149-154. doi: 10.1016/j.remn.2020.06.003. Epub 2021 Jan 21.
Impact factor: 1.359
Publication type: Paper in national publication
Authors: Bergesio, Fabrizio, De Maggi, Adriano, Coronado, Monica, Pardal, Emilia, Plaza, Rafael, Hernandez, Ana Cristina, Sarandeses, Maria Del Pilar, Cortes, Montserrat, Setoain, Xavier, Simo, Marc et al.
DOI: 10.1016/j.remn.2020.06.003

Blog

News

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The device, called Winco USG, is a simulation platform for holistic and integrated training of professionals performing this type of procedure.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.